Uncover key drivers, emerging technologies, and competitive movements shaping the point of care hematology diagnostics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present And Forecasted Size Of The Point Of Care Hematology Diagnostics Market?

The point of care hematology diagnostics market size has demonstrated robust growth over recent years. It is anticipated to expand from $2.66 billion in 2024 to $2.90 billion in 2025, at a compound annual growth rate (CAGR) of 9.1%. This historical market expansion is primarily due to the increasing occurrence of hematological conditions, the expansion of decentralized healthcare models, a greater emphasis on early disease identification, rising healthcare investments in developing markets, and the wider deployment of portable diagnostic instruments.

The point of care hematology diagnostics market size is anticipated to experience robust expansion over the coming years. This market is projected to reach $4.05 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.7%. This projected growth during the forecast period is primarily driven by the increasing adoption of personalized medicine, a rising demand for immediate clinical decisions, the expanding need for home healthcare diagnostics, the growing prevalence of blood-related disorders, and enhanced awareness regarding preventive healthcare. Significant trends anticipated in the forecast period involve advanced connectivity features in hematology analyzers, ongoing innovation in sample preparation methods, the integration of artificial intelligence into diagnostic tools, developments in single-cell analysis, the incorporation of cloud-based data platforms, and progress in lab-on-a-chip solutions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27388&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Point Of Care Hematology Diagnostics Market?

The expanding occurrence of blood-related ailments is anticipated to fuel the expansion of the point-of-care hematology diagnostics market in the future. These conditions involve abnormalities in the various constituents of blood, such as red blood cells, white blood cells, platelets, or plasma. The heightened incidence of blood disorders largely stems from the growing presence of chronic illnesses, which directly affect blood health and necessitate continuous oversight. Point-of-care hematology diagnostics facilitate prompt detection and ongoing surveillance of blood disorders by delivering fast, precise results directly at or close to the patient care location, leading to faster clinical judgments and enhanced disease control. For example, in April 2024, the Perth Blood Institute, an Australian non-profit, reported that the count of individuals diagnosed with hemophilia (a hereditary blood condition where blood fails to clot properly, leading to extended bleeding) reached 257,146 in 2022, an increase from 233,577 in 2021. Consequently, the increasing frequency of blood disorders is propelling the development of the point-of-care hematology diagnostics market.

What Are The Key Segment Trends Observed In The Point Of Care Hematology Diagnostics Market?

The point of care hematology diagnostics market covered in this report is segmented

1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types

2) By Product: Consumables, Systems

3) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product

4) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users

Subsegments:

1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)

2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level

3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin

4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation

5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing

Which Disruptive Trends Are Driving Change Across The Point Of Care Hematology Diagnostics Market?

Leading companies within the point-of-care hematology diagnostics market are concentrating on developing state-of-the-art products, such as cartridge-based AI-powered hematology analyzers, to provide quick, precise, and on-site blood analysis for better patient care. These analyzers are compact diagnostic devices that utilize single-use reagent cartridges and artificial intelligence algorithms to efficiently and accurately analyze blood samples directly at the point of care. For example, in September 2024, Zoetis Inc., a US-based veterinary health company, launched Vetscan OptiCell, which is a cartridge-based, AI-powered hematology analyzer specifically designed for veterinary applications. This innovative system delivers rapid, reference laboratory-quality complete blood count (CBC) results in mere minutes at the point of care, while also reducing maintenance and operational time. It features advanced AI-driven image analysis and viscoelastic focusing technology that meticulously aligns cells for clear imaging, allowing for accurate blood cell classification and automated abnormality detection, thereby ensuring efficient and reliable veterinary diagnostics.

Who Are The Leading Companies Driving The Point Of Care Hematology Diagnostics Market?

Major companies operating in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., Medsource Ozone Biomedicals Pvt. Ltd., BioSystems S.A., Chengdu Seamaty Technology Co. Ltd., Drucker Diagnostics LLC, Diamond Diagnostics Inc., DIAGON Kft., BioMedomics Inc., Norma Instruments Zrt., PixCell Medical Technologies Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/point-of-care-hematology-diagnostics-global-market-report

Which Region Is Forecasted To Lead The Point Of Care Hematology Diagnostics Market In The Coming Years?

North America was the largest region in the point of care hematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27388&type=smp

Browse Through More Reports Similar to the Global Point Of Care Hematology Diagnostics Market 2025, By The Business Research Company

Pre Engineered Buildings Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pre-engineered-buildings-global-market-report

Architectural And Structural Metals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/architectural-and-structural-metals-global-market-report

Buildings Construction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/buildings-construction-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model